Insmed | Sustainability Performance
Specializes in developing therapies for rare diseases, with a focus on conditions involving serious unmet medical needs. Research and clinical efforts concentrate on complex respiratory and inflammatory disorders, supported by a pipeline of drug candidates progressing through different stages of regulatory approval.
1988
United States
1,001 - 5,000 employees
Biotechnology
$500M - 1B in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8553
Overallⓘ#1968
in United Statesⓘ#198
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
Powered by illuminem
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
7-10
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.